1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc XNAS: BEAM
29.02 -1.68 (-5.47%)
2.1M
XNAS Volume

XNAS 28 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 16 analysts

Beam Therapeutics Inc has a share price target of US$ 47, revenue growth forecast of -39.1%, and profit growth estimate of -6.8% for FY25, based on top 16 analyst calls.